Everest Organics [EVERESTO] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Everest Organics Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Everest Organics Ltd. wins in 9 metrics, Gujarat Themis Biosyn Ltd. wins in 10 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Everest Organics Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 52.29 73.73 Everest Organics Ltd.
Price-to-Book Ratio 3.71 13.36 Everest Organics Ltd.
Debt-to-Equity Ratio 68.11 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio -0.71 -17.55 Everest Organics Ltd.
EV/EBITDA 18.13 52.76 Everest Organics Ltd.
Profit Margin (TTM) 3.08% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 5.30% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 5.30% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity -1.84% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) -0.57% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-108.03M $-251.22M Everest Organics Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -37.06% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.42 22.23 Everest Organics Ltd.
Enterprise Value $3.19B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 1.69 22.65 Everest Organics Ltd.
Gross Profit Margin (TTM) 38.71% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $197 $15 Everest Organics Ltd.
Earnings per Share (Diluted) $5.29 $4.40 Everest Organics Ltd.
Beta (Stock Volatility) 0.43 -0.17 Gujarat Themis Biosyn Ltd.

Everest Organics Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

EVERESTO
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Everest Organics Ltd.6.20%-10.00%-11.08%-15.32%-43.80%-53.20%
Gujarat Themis Biosyn Ltd.2.45%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Everest Organics Ltd.-37.06%167.84%-27.25%931.92%6,868.83%6,868.83%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Everest Organics Ltd. vs Gujarat Themis Biosyn Ltd.

MetricEVERESTOGUJTHEM
Market Information
Market Cap i₹2.64B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,48279,452
90 Day Avg. Volume i9,199106,446
Last Close₹248.50₹411.65
52 Week Range₹197.00 - ₹536.40₹225.05 - ₹479.00
% from 52W High-53.67%-14.06%
All-Time High₹536.40 (Jan 02, 2026)₹479.00 (Oct 27, 2025)
% from All-Time High-53.67%-14.06%
Growth Metrics
Quarterly Revenue Growth0.02%0.10%
Quarterly Earnings Growth-0.69%-0.04%
Financial Health
Profit Margin (TTM) i0.03%0.30%
Operating Margin (TTM) i0.05%0.40%
Return on Equity (TTM) i-0.02%0.20%
Debt to Equity (MRQ) i68.1127.04
Cash & Liquidity
Book Value per Share (MRQ)₹74.65₹24.29
Cash per Share (MRQ)₹1.08₹0.92
Operating Cash Flow (TTM) i₹38.10M₹970.68M
Levered Free Cash Flow (TTM) i₹-12,903,000₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend i₹0.00₹0.67

Valuation & Enterprise Metrics Analysis: Everest Organics Ltd. vs Gujarat Themis Biosyn Ltd.

MetricEVERESTO (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i52.2973.73
Forward P/E iN/AN/A
PEG Ratio i-0.71-17.55
Price to Sales (TTM) i1.4222.23
Price to Book (MRQ) i3.7113.36
Market Capitalization
Market Capitalization i₹2.64B₹35.41B
Enterprise Value i₹3.19B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i1.6922.65
Enterprise to EBITDA i18.1352.76
Risk & Other Metrics
Beta i0.43-0.17
Book Value per Share (MRQ) i₹74.65₹24.29

Financial Statements Comparison: Everest Organics Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVERESTO (2025)GUJTHEM (2025)
Revenue/Sales i1.59B1.51B
Cost of Goods Sold i985.43M318.78M
COGS % of Revenue i61.8%21.1%
Gross Profit i609.36M1.19B
Gross Margin i38.2%78.9%
Research & Development i8.29M34.37M
Operating Income (EBIT) i23.83M642.49M
Operating Margin i1.5%42.6%
EBITDA i78.09M713.04M
EBITDA Margin i4.9%47.3%
Pre-Tax Income i-32.43M655.38M
Pre-Tax Income % of Revenue i-2.0%43.5%
Income Tax i-19.52M167.66M
Income Tax % of Revenue i-1.2%11.1%
Net Income (Profit) i-12.90M487.72M
Profit Margin i-0.8%32.3%

Balance Sheet & Liquidity Metrics

MetricEVERESTO (2025)GUJTHEM (2025)
Cash & Equivalents i60.92M116.94M
Total Current Assets i1.48B519.73M
Total Current Assets % of Revenue i92.7%34.5%
Total Current Liabilities i1.40B205.60M
Total Current Liabilities % of Revenue i87.7%13.6%
Long-Term Debt i91.98M296.36M
Long-Term Debt % of Revenue i5.8%19.7%
Total Shareholders Equity i699.47M2.48B
Retained Earnings i312.18M2.37B
Retained Earnings % of Revenue i19.6%157.4%
Property, Plant & Equipment i483.39M411.30M

Cash Flow Statement Comparison

MetricEVERESTO (2025)GUJTHEM (2025)
Operating Cash Flow i38.10M970.68M
Operating Cash Flow % of Revenue i2.4%64.4%
Capital Expenditures i-35.77M-1.16B
Free Cash Flow i-108.03M-251.22M
FCF Margin i-6.8%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricEVERESTOGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.71M108.97M
Float Shares i978,95829.52M
% Held by Insiders i76.90%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i23.10%26.84%

Dividend Analysis & Yield Comparison: Everest Organics Ltd. vs Gujarat Themis Biosyn Ltd.

MetricEVERESTOGUJTHEM
Last 12-Month Dividend i₹0.00₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend i₹0.17₹0.22
3-Year Avg Dividend Yield i0.35%0.17%
3-Year Total Dividends i₹0.50₹0.67
Ex-Dividend DateSep 15, 2022Sep 04, 2025